pubmed-article:21419770 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21419770 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21419770 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
pubmed-article:21419770 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
pubmed-article:21419770 | lifeskim:mentions | umls-concept:C0796545 | lld:lifeskim |
pubmed-article:21419770 | lifeskim:mentions | umls-concept:C0677908 | lld:lifeskim |
pubmed-article:21419770 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:21419770 | pubmed:dateCreated | 2011-6-6 | lld:pubmed |
pubmed-article:21419770 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:abstractText | Several studies have reported that low doses of interferon can delay the development of hepatocellular carcinoma (HCC) and progression of chronic hepatitis C. We investigated the incidence of clinical events among participants of the Evaluation of PegIntron in Control of Hepatitis C Cirrhosis (EPIC)3 program. | lld:pubmed |
pubmed-article:21419770 | pubmed:language | eng | lld:pubmed |
pubmed-article:21419770 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21419770 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21419770 | pubmed:month | Jun | lld:pubmed |
pubmed-article:21419770 | pubmed:issn | 1528-0012 | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:ColomboMassim... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:PoynardThierr... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BruixJordiJ | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BedossaPierre... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:AlbrechtJanic... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BoparaiNavdee... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:NiederauClaus... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BergThomasT | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:SchiffEugeneE | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:GriffelLouis... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:TergRubenR | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BurakKellyK | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BrassClifford... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:BurroughsMarg... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:HeathcoteEliz... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:PooJorge-Luis... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:MelloCarlos... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:GuentherRaine... | lld:pubmed |
pubmed-article:21419770 | pubmed:author | pubmed-author:EPIC3 Study... | lld:pubmed |
pubmed-article:21419770 | pubmed:copyrightInfo | Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:21419770 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21419770 | pubmed:volume | 140 | lld:pubmed |
pubmed-article:21419770 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21419770 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21419770 | pubmed:pagination | 1990-9 | lld:pubmed |
pubmed-article:21419770 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:meshHeading | pubmed-meshheading:21419770... | lld:pubmed |
pubmed-article:21419770 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21419770 | pubmed:articleTitle | Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. | lld:pubmed |
pubmed-article:21419770 | pubmed:affiliation | BCLC Group, Liver Unit, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Hepatología y Enfermedades Digestivas, Barcelona, Spain. jbruix@clinic.ub.es | lld:pubmed |
pubmed-article:21419770 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21419770 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:21419770 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:21419770 | pubmed:publicationType | Multicenter Study | lld:pubmed |